117 related articles for article (PubMed ID: 28729695)
1. The Epstein-Barr Virus BRRF1 Gene Is Dispensable for Viral Replication in HEK293 cells and Transformation.
Yoshida M; Watanabe T; Narita Y; Sato Y; Goshima F; Kimura H; Murata T
Sci Rep; 2017 Jul; 7(1):6044. PubMed ID: 28729695
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production.
Masud HMAA; Watanabe T; Yoshida M; Sato Y; Goshima F; Kimura H; Murata T
J Virol; 2017 Dec; 91(23):. PubMed ID: 28904200
[TBL] [Abstract][Full Text] [Related]
3. EBI2 expression in B lymphocytes is controlled by the Epstein-Barr virus transcription factor, BRRF1 (Na), during viral infection.
Cornaby C; Jafek JL; Birrell C; Mayhew V; Syndergaard L; Mella J; Cheney W; Poole BD
J Gen Virol; 2017 Mar; 98(3):435-446. PubMed ID: 27902324
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
[TBL] [Abstract][Full Text] [Related]
5. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
6. BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells.
Wang H; Zhao Y; Zeng L; Tang M; El-Deeb A; Li JJ; Cao Y
Anticancer Res; 2004; 24(1):67-74. PubMed ID: 15015577
[TBL] [Abstract][Full Text] [Related]
7. Latent and lytic Epstein-Barr virus replication strategies.
Tsurumi T; Fujita M; Kudoh A
Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
[TBL] [Abstract][Full Text] [Related]
8. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
9. Roles of Epstein-Barr virus BGLF3.5 gene and two upstream open reading frames in lytic viral replication in HEK293 cells.
Watanabe T; Fuse K; Takano T; Narita Y; Goshima F; Kimura H; Murata T
Virology; 2015 Sep; 483():44-53. PubMed ID: 25965794
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Promotes EBV Reactivation through Activation of the p38 Mitogen-Activated Protein Kinase.
Liu X; Cohen JI
J Virol; 2016 Jan; 90(2):1129-38. PubMed ID: 26559845
[TBL] [Abstract][Full Text] [Related]
11. Role of the TSG101 gene in Epstein-Barr virus late gene transcription.
Chua HH; Lee HH; Chang SS; Lu CC; Yeh TH; Hsu TY; Cheng TH; Cheng JT; Chen MR; Tsai CH
J Virol; 2007 Mar; 81(5):2459-71. PubMed ID: 17182691
[TBL] [Abstract][Full Text] [Related]
12. Encyclopedia of EBV-Encoded Lytic Genes: An Update.
Murata T
Adv Exp Med Biol; 2018; 1045():395-412. PubMed ID: 29896677
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the epstein-barr virus BRRF1 gene, located between early genes BZLF1 and BRLF1.
Segouffin-Cariou C; Farjot G; Sergeant A; Gruffat H
J Gen Virol; 2000 Jul; 81(Pt 7):1791-9. PubMed ID: 10859385
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication.
Saito S; Murata T; Kanda T; Isomura H; Narita Y; Sugimoto A; Kawashima D; Tsurumi T
J Virol; 2013 Apr; 87(7):4060-70. PubMed ID: 23365429
[TBL] [Abstract][Full Text] [Related]
15. The Translesion Polymerase Pol η Is Required for Efficient Epstein-Barr Virus Infectivity and Is Regulated by the Viral Deubiquitinating Enzyme BPLF1.
Dyson OF; Pagano JS; Whitehurst CB
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724765
[TBL] [Abstract][Full Text] [Related]
16. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
[TBL] [Abstract][Full Text] [Related]
17. NF-kappaB inhibitors induce lytic cytotoxicity in Epstein-Barr virus-positive nasopharyngeal carcinoma cells.
Liu SF; Wang H; Lin XC; Xiang H; Deng XY; Li W; Tang M; Cao Y
Cell Biol Int; 2008 Aug; 32(8):1006-13. PubMed ID: 18579417
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Epstein-Barr virus and cellular gene expression during the early phases of Epstein-Barr virus lytic induction.
Auburn H; Zuckerman M; Smith M
J Med Microbiol; 2016 Nov; 65(11):1243-1252. PubMed ID: 27625030
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus Lytic Cycle Reactivation.
McKenzie J; El-Guindy A
Curr Top Microbiol Immunol; 2015; 391():237-61. PubMed ID: 26428377
[TBL] [Abstract][Full Text] [Related]
20. Efficient production of infectious viruses requires enzymatic activity of Epstein-Barr virus protein kinase.
Murata T; Isomura H; Yamashita Y; Toyama S; Sato Y; Nakayama S; Kudoh A; Iwahori S; Kanda T; Tsurumi T
Virology; 2009 Jun; 389(1-2):75-81. PubMed ID: 19427010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
